Review Article| Volume 11, ISSUE 2, P237-243, March 2020

Embracing the complexity: Older adults with cancer-related cognitive decline—A Young International Society of Geriatric Oncology position paper

Published:October 13, 2019DOI:


      Cancer-related cognitive decline (CRCD) may have particularly significant consequences for older adults, impacting their functional and physical abilities, level of independence, ability to make decisions, treatment adherence, overall quality of life, and ultimately survival. In honor of Dr. Hurria's work we explore and examine multiple types of screening, assessment and non-pharmacologic treatments for CRCD. We then suggest future research and clinical practice questions to holistically appreciate the complexity of older adults with cancer's experiences and fully integrate the team-based approach to best serve this population.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Robb C.
        • et al.
        Patterns of care and survival in cancer patients with cognitive impairment.
        Crit Rev Oncol Hematol. 2010; 74: 218-224
        • Barrios H.
        • et al.
        Quality of life in patients with mild cognitive impairment.
        Aging Ment Health. 2013; 17: 287-292
        • Stilley C.S.
        • et al.
        The impact of cognitive function on medication management: three studies.
        Health Psychol. 2010; 29: 50-55
        • Park D.C.
        • Reuter-Lorenz P.
        The adaptive brain: aging and neurocognitive scaffolding.
        Annu Rev Psychol. 2009; 60: 173-196
        • Wefel J.S.
        • et al.
        Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
        CA Cancer J Clin. 2015; 65: 123-138
        • Ahles T.A.
        Brain vulnerability to chemotherapy toxicities.
        Psychooncology. 2012; 21: 1141-1148
        • Hurria A.
        • Jones L.
        • Muss H.B.
        Cancer treatment as an accelerated aging process: assessment, biomarkers, and interventions.
        Am Soc Clin Oncol Educ Book. 2016; 35: e516-e522
        • Mandelblatt J.S.
        • et al.
        Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living with cancer study.
        J Clin Oncol. 2018; 36: 3211-3222
        • Mandelblatt J.S.
        • et al.
        Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).
        Cancer. 2016; 122: 3555-3563
        • Lange M.
        • et al.
        Cognitive changes after adjuvant treatment in older adults with early-stage breast cancer.
        Oncologist. 2019; 24: 62-68
        • Ahles T.A.
        • Root J.C.
        • Ryan E.L.
        Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.
        J Clin Oncol. 2012; 30: 3675-3686
        • Janelsins M.C.
        • et al.
        Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study.
        J Clin Oncol. 2017; 35: 506-514
        • Hurria A.
        • et al.
        Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
        J Am Geriatr Soc. 2006; 54: 925-931
        • Stavraka C.
        • et al.
        A study of symptoms described by ovarian cancer survivors.
        Gynecol Oncol. 2012; 125: 59-64
        • Amidi A.
        • et al.
        Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy.
        JNCI: J Natl Cancer Inst. 2017; 109 ([p. djx085-djx085])
        • Amidi A.
        • et al.
        Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment.
        Support Care Cancer. 2015; 23: 2973-2979
        • Regier N.G.
        • et al.
        Cancer-related cognitive impairment and associated factors in a sample of older male oral-digestive cancer survivors.
        Psycho-Oncol. 2019; 28: 1551-1558
        • Vardy J.
        • et al.
        Cognitive function and fatigue after diagnosis of colorectal cancer.
        Ann Oncol. 2014; 25: 2404-2412
        • Meadows M.E.
        • et al.
        Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome.
        Arch Clin Neuropsychol. 2013; 28: 363-374
        • Saeed O.
        • et al.
        Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis.
        J Cancer Surviv. 2019; 13: 231-243
        • Sun M.
        • et al.
        Cognitive impairment in men with prostate cancer treated with androgen deprivation therapy: a systematic review and meta-analysis.
        J Urol. 2018; 199: 1417-1425
        • Hurria A.
        • Somlo G.
        • Ahles T.
        Renaming "chemobrain".
        Cancer Invest. 2007; 25: 373-377
        • Hurria A.
        • et al.
        Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
        Breast Cancer Res Treat. 2006; 98: 343-348
        • Ahles T.A.
        • et al.
        Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.
        J Clin Oncol. 2010; 28: 4434-4440
        • Jim H.S.
        • et al.
        Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
        J Clin Oncol. 2012; 30: 3578-3587
        • Bender C.M.
        • et al.
        Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
        Menopause. 2007; 14: 995-998
        • Castellon S.A.
        • et al.
        Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
        J Clin Exp Neuropsychol. 2004; 26: 955-969
        • Hurria A.
        • et al.
        The effect of aromatase inhibition on the cognitive function of older patients with breast cancer.
        Clin Breast Cancer. 2014; 14: 132-140
        • Phillips K.A.
        • et al.
        Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.
        Breast Cancer Res Treat. 2011; 126: 221-226
        • Schilder C.M.
        • et al.
        Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.
        J Clin Oncol. 2010; 28: 1294-1300
        • Van Dyk K.
        • Crespi C.M.
        • Bower J.E.
        • Castellon S.A.
        • Petersen L.
        • Ganz P.A.
        The cognitive effects of endocrine therapy in survivors of breast cancer: a prospective longitudinal study up to 6 years after treatment.
        Cancer. 2019; 125: 681-689
        • Bluethmann S.M.
        • et al.
        Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
        Breast Cancer Res Treat. 2017; 165: 677-686
        • Magnuson A.
        • et al.
        Longitudinal relationship between frailty and cognition in patients 50 years and older with breast cancer.
        J Am Geriatr Soc. 2019; 67: 928-936
        • Inouye S.K.
        • et al.
        The short-term and long-term relationship between delirium and cognitive trajectory in older surgical patients.
        Alzheimers Dement. 2016; 12: 766-775
        • Fong T.G.
        • et al.
        The interface between delirium and dementia in elderly adults.
        Lancet Neurol. 2015; 14: 823-832
        • Samuel M.
        Postoperative delirium in older adults: best practice statement from the American Geriatrics Society.
        JMAGSEP. 2015; 220: 136-149
        • Balducci L.
        • Goetz-Parten D.
        • Steinman M.A.
        Polypharmacy and the management of the older cancer patient.
        Ann Oncol. 2013; 24: vii36-40
        • Maggiore R.J.
        • Gross C.P.
        • Hurria A.
        Polypharmacy in older adults with cancer.
        Oncologist. 2010; 15: 507-522
        • Janelsins M.C.
        • et al.
        Prevalence, mechanisms, and management of cancer-related cognitive impairment.
        Int Rev Psychiatry. 2014; 26: 102-113
        • Simo M.
        • et al.
        Chemobrain: a systematic review of structural and functional neuroimaging studies.
        Neurosci Biobehav Rev. 2013; 37: 1311-1321
        • Deprez S.
        • et al.
        Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.
        J Clin Oncol. 2012; 30: 274-281
        • Kesler S.
        • et al.
        Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors.
        Brain Behav Immun. 2013; 30: S109-S116
        • McDonald B.C.
        • et al.
        Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.
        Breast Cancer Res Treat. 2010; 123: 819-828
        • McDonald B.C.
        • et al.
        Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.
        Brain Behav Immun. 2013; 30: S117-S125
        • McDonald B.C.
        • Saykin A.J.
        Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.
        Brain Imaging Behav. 2013; 7: 374-387
        • Ahles T.A.
        • et al.
        Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.
        Psychooncology. 2014; 23: 1382-1390
        • Small B.J.
        • et al.
        Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors.
        Cancer. 2011; 117: 1369-1376
        • Koleck T.A.
        • et al.
        An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
        Breast Cancer (Dove Med Press). 2017; 9: 95-110
        • Beglinger L.J.
        • et al.
        Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study.
        J Int Neuropsychol Soc. 2007; 13: 172-177
        • Harder H.
        • et al.
        Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative study.
        Eur J Cancer. 2005; 41: 1007-1016
        • Sostak P.
        • et al.
        Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.
        Neurology. 2003; 60: 842-848
        • Sharafeldin N.
        • et al.
        Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study.
        J Clin Oncol. 2018; 36: 463-475
        • Stern Y.
        Cognitive reserve.
        Neuropsychologia. 2009; 47: 2015-2028
        • Amidi A.
        • Wu L.M.
        • Agerbæk M.
        • Larsen P.L.
        • Pedersen A.D.
        • Mehlsen M.
        • Zachariae R.
        Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients.
        Psycho-Oncology. 2015; 24: 1174-1180
        • Selamat M.H.
        • et al.
        Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.
        PLoS One. 2014; 9e108002
        • VanderWalde N.
        • et al.
        NCCN guidelines insights: older adult oncology, version 2.2016.
        J Natl Compr Canc Netw. 2016; 14: 1357-1370
        • Network, N.C.C
        NCCN Guidelines Version 1.2019 Older Adult Oncology. 2019 January 2019 [cited 2019 July 12, 2019]; 1.
        (Available from)
        • Mohile S.G.
        • et al.
        Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology.
        J Clin Oncol. 2018; 36: 2326-2347
        • Boyle H.J.
        • et al.
        Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients.
        Eur J Cancer. 2019; 116: 116-136
        • Droz J.-P.
        • et al.
        Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.
        Crit Rev Oncol Hematol. 2010; 73: 68-91
        • Hurria A.
        • et al.
        Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.
        J Clin Oncol. 2011; 29: 1290
        • Jolly T.A.
        • et al.
        Geriatric assessment-identified deficits in older cancer patients with normal performance status.
        Oncologist. 2015; 20: 379-385
        • Mohile S.G.
        • Dale W.
        • Somerfield M.R.
        • Schonberg M.A.
        • Boyd C.M.
        • Burhenn P.S.
        • Janelsins M.C.
        Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology.
        J Clin Oncol Off J Am Soc Clin Oncol. 2018; 36: 2326-2347
        • Mohile S.G.
        • et al.
        Community oncologists' decision-making for treatment of older patients with cancer.
        J Natl Compr Canc Netw. 2018; 16: 301-309
        • Wildiers H.
        • et al.
        International society of geriatric oncology consensus on geriatric assessment in older patients with cancer.
        J Clin Oncol. 2014; 32: 2595-2603
        • Williams G.R.
        Geriatric assessment: precision medicine for older adults with cancer.
        J Oncol Pract. 2018; 14: 97-98
        • Hurria A.
        • et al.
        Validation of a prediction tool for chemotherapy toxicity in older adults with cancer.
        J Clin Oncol. 2016; 34: 2366
        • Extermann M.
        • Hurria A.
        Comprehensive geriatric assessment for older patients with cancer.
        J Clin Oncol. 2007; 25: 1824-1831
        • Borson S.
        • et al.
        The Mini-Cog as a screen for dementia: validation in a population-based sample.
        J Am Geriatr Soc. 2003; 51: 1451-1454
        • Nasreddine Z.S.
        • et al.
        The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment.
        J Am Geriatr Soc. 2005; 53: 695-699
        • Folstein M.
        • Folstein S.E.
        • McHugh P.R.
        Mini-mental state. A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Katzman R.
        • et al.
        Validation of a short orientation-memory-concentration test of cognitive impairment.
        Am J Psychiatry. 1983; 140: 734-739
        • Olson R.
        • et al.
        Prospective comparison of the prognostic utility of the mini mental state examination and the montreal cognitive assessment in patients with brain metastases.
        Support Care Cancer. 2011; 19: 1849-1855
        • Olson R.A.
        • et al.
        Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life.
        J Neurooncol. 2011; 105: 337
        • Rambeau A.
        • et al.
        Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology.
        J Geriatr Oncol. 2019; 10: 235-240
        • Savard J.
        • Ganz P.A.
        Subjective or objective measures of cognitive functioning-What's more important?.
        JAMA Oncol. 2016; 2: 1263-1264
        • Costa D.S.J.
        • et al.
        The structure of the FACT-Cog v3 in cancer patients, students, and older adults.
        J Pain Symptom Manage. 2018; 55: 1173-1178
        • Pergolotti M.
        • Langer M.M.
        • Deal A.M.
        • Muss H.B.
        • Nyrop K.
        • Williams G.
        Mental status evaluation in older adults with cancer: development of the mental health Index-13.
        J Geriatr Oncol. 2019; 10: 241-245
        • Marc L.G.
        • Raue P.J.
        • Bruce M.L.
        Screening performance of the 15-item geriatric depression scale in a diverse elderly home care population.
        Am J Geriatr Psychiatry. 2008; 16: 914-921
        • Parsons M.W.
        • Dietrich J.
        Assessment and management of cognitive changes in patients with cancer.
        Cancer. 2019 Jun 15; 125: 1958-1962
        • Potter D.
        • Keeling D.
        Effects of moderate exercise and circadian rhythms on human memory.
        J Sport Exerc Psychol. 2005; 27
        • Wefel J.S.
        • et al.
        International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer.
        Lancet Oncol. 2011; 12: 703-708
        • Courtier N.
        • et al.
        Cancer and dementia: an exploratory study of the experience of cancer treatment in people with dementia.
        Psycho-Oncology. 2016; 25: 1079-1084
        • Auyeung T.W.
        • et al.
        Physical frailty predicts future cognitive decline—a four-year prospective study in 2737 cognitively normal older adults.
        J Nutr Health Aging. 2011; 15: 690-694
        • Robertson D.A.
        • Savva G.M.
        • Kenny R.A.
        Frailty and cognitive impairment—a review of the evidence and causal mechanisms.
        Ageing Res Rev. 2013; 12: 840-851
        • Loh K.P.
        • et al.
        What every oncologist should know about geriatric assessment for older patients with cancer: young international society of geriatric oncology position paper.
        J Oncol Pract. 2018; 14: 85-94
        • Ahles T.A.
        • Hurria A.
        New challenges in psycho-oncology research IV: cognition and cancer: conceptual and methodological issues and future directions.
        Psycho-oncology. 2018; 27: 3-9
        • Grajo L.C.
        • Gutman S.A.
        The role of occupational therapy in functional literacy.
        Open J Occup Ther. 2019; 7: 13
        • Speck R.M.
        • et al.
        An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.
        J Cancer Surviv. 2010; 4: 87-100
        • Schmitz K.H.
        • et al.
        American college of sports medicine roundtable on exercise guidelines for cancer survivors.
        Med Sci Sports Exerc. 2010; 42: 1409-1426
        • Schmitz K.H.
        • et al.
        Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.
        Cancer Epidemiol Prev Biomark. 2005; 14: 1588-1595
        • Courneya K.S.
        Exercise in cancer survivors: an overview of research.
        Med Sci Sports Exerc. 2003; 35: 1846-1852
        • Hillman C.H.
        • Erickson K.I.
        • Kramer A.F.
        Be smart, exercise your heart: exercise effects on brain and cognition.
        Nat Rev Neurosci. 2008; 9: 58
        • Warburton D.E.
        • Nicol C.W.
        • Bredin S.S.
        Health benefits of physical activity: the evidence.
        Cmaj. 2006; 174: 801-809
        • Piercy K.L.
        • et al.
        The physical activity guidelines for Americans.
        Jama. 2018; 320: 2020-2028
        • Northey J.M.
        • et al.
        Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis.
        Br J Sports Med. 2018; 52: 154-160
        • Gajewski P.D.
        • Falkenstein M.
        Physical activity and neurocognitive functioning in aging-a condensed updated review.
        Eur Rev Aging Phys Act. 2016; 13: 1
        • Sofi F.
        • et al.
        Physical activity and risk of cognitive decline: a meta-analysis of prospective studies.
        J Intern Med. 2011; 269: 107-117
        • Prakash R.S.
        • et al.
        Physical activity and cognitive vitality.
        Annu Rev Psychol. 2015; 66: 769-797
        • Bherer L.
        • Erickson K.I.
        • Liu-Ambrose T.
        A review of the effects of physical activity and exercise on cognitive and brain functions in older adults.
        J Aging Res. 2013; 2013
        • Kramer A.F.
        • Erickson K.I.
        Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function.
        Trends Cogn Sci. 2007; 11: 342-348
        • Colcombe S.J.
        • et al.
        Aerobic exercise training increases brain volume in aging humans.
        J Gerontol A Biol Sci Med Sci. 2006; 61: 1166-1170
        • Zimmer P.
        • et al.
        Effects of exercise interventions and physical activity behavior on cancer related cognitive impairments: a systematic review.
        Biomed Res Int. 2016; 2016: 13
        • Myers J.S.
        • et al.
        Exercise as an intervention to mitigate decreased cognitive function from cancer and cancer treatment: an integrative review.
        Cancer Nurs. 2018; 41: 327-343
        • Voss M.W.
        • et al.
        Bridging animal and human models of exercise-induced brain plasticity.
        Trends Cogn Sci. 2013; 17: 525-544
        • Blake H.
        Physical activity and exercise in the treatment of depression.
        Front Psych. 2012; 3: 106
        • Park H.-S.
        • et al.
        Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
        Neuropharmacology. 2018; 133: 451-461
        • Miki E.
        • Kataoka T.
        • Okamura H.
        Feasibility and efficacy of speed-feedback therapy with a bicycle ergometer on cognitive function in elderly cancer patients in Japan.
        Psycho-Oncology. 2014; 23: 906-913
        • Baumann F.T.
        • et al.
        12-week resistance training with breast cancer patients during chemotherapy: effects on cognitive abilities.
        Breast Care. 2011; 6: 142-143
        • Galvao D.A.
        • et al.
        Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial.
        J Clin Oncol. 2010; 28: 340-347
        • Mustian K.M.
        • et al.
        EXCAP exercise effects on cognitive impairment and inflammation: A URCC NCORP RCT in 479 cancer patients.
        American Society of Clinical Oncology, 2015
        • Schmidt M.E.
        • et al.
        Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: a randomized controlled trial.
        Int J Cancer. 2015; 137: 471-480
        • Leach H.J.
        • et al.
        Evaluation of a community-based exercise program for breast cancer patients undergoing treatment.
        Cancer Nurs. 2015; 38: 417-425
        • Speck R.M.
        • et al.
        Changes in the body image and relationship scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema.
        Breast Cancer Res Treat. 2010; 121: 421-430
        • Myers J.S.
        Chemotherapy-related cognitive impairment: neuroimaging, neuropsychological testing, and the neuropsychologist.
        Clin J Oncol Nurs. 2009; 13
        • Gentry A.L.
        • et al.
        Protocol for Exercise Program in Cancer and Cognition (EPICC): a randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy.
        Contemp Clin Trials. 2018; 67: 109-115
        • Campbell K.
        • et al.
        Effect of aerobic exercise on cancer-associated cognitive impairment: a proof-of-concept RCT.
        Psycho-oncology. 2018; 27: 53-60
        • Northey J.M.
        • Pumpa K.L.
        • Quinlan C.
        • Ikin A.
        • Toohey K.
        • Smee D.J.
        • Rattray B.
        Cognition in breast cancer survivors: a pilot study of interval and continuous exercise.
        J Sci Med Sport. 2019; 22: 580-585
        • Hartman S.J.
        • et al.
        Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: the memory & motion study.
        Cancer. 2018; 124: 192-202
        • Von Ah D.
        • Jansen C.E.
        • Allen D.H.
        Evidence-based interventions for cancer and treatment-related cognitive impairment.
        J Clin Nurs Oncol. 2014; 18
        • Reid-Arndt S.A.
        • et al.
        Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.
        J Psychosoc Oncol. 2009; 27: 415-434
        • Oh B.
        • et al.
        Effect of medical qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial.
        Support Care Cancer. 2012; 20
        • Gillespie L.D.
        • et al.
        Interventions for preventing falls in older people living in the community.
        Cochrane Database Syst Rev. 2012; 9
        • Zeng Y.
        • Xie X.
        • Cheng A.S.
        Qigong or Tai Chi in cancer care: an updated systematic review and meta-analysis.
        Curr Oncol Rep. 2019; 21: 48
        • Derry H.M.
        • et al.
        Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial.
        Psycho-Oncology. 2015; 24: 958-966
        • Janelsins M.C.
        • et al.
        YOCAS©® yoga reduces self-reported memory difficulty in cancer survivors in a nationwide randomized clinical trial: investigating relationships between memory and sleep.
        Integr Cancer Ther. 2016; 15: 263-271
        • Latte-Naor S.
        • Mao J.J.
        Putting integrative oncology into practice: concepts and approaches.
        J Oncol Pract. 2019; 15: 7-14
        • Chiesa A.
        • Calati R.
        • Serretti A.
        Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings.
        Clin Psychol Rev. 2011; 31: 449-464
        • Lengacher C.A.
        • et al.
        Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast Cancer survivors: a randomized controlled trial.
        J Clin Oncol. 2016; 34: 2827-2834
        • Johns S.A.
        • et al.
        Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors.
        Support Care Cancer. 2016; 24: 4085-4096
        • Cifu G.
        • et al.
        Mindfulness-based interventions and cognitive function among breast cancer survivors: a systematic review.
        BMC Cancer. 2018; 18: 1163
        • Boss L.
        • Kang D.-H.
        • Branson S.
        Loneliness and cognitive function in the older adult: a systematic review.
        Int Psychogeriatr. 2015; 27: 541-553
        • Adams R.N.
        • et al.
        Cognitive and situational precipitants of Cancer Patients' loneliness: A qualitative analysis. In oncology nursing forum.
        NIH Public Access, 2016
        • Jaremka L.M.
        • et al.
        Cognitive problems among breast cancer survivors: loneliness enhances risk.
        Psycho-Oncol. 2014; 23: 1356-1364
        • Ferguson R.J.
        • et al.
        Development of CBT for chemotherapy-related cognitive change: results of a waitlist control.
        Psycho-Oncol. 2012; : 21
        • Ferguson R.J.
        • et al.
        A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
        Cancer. 2016; 122: 1782-1791
        • Ferguson R.J.
        • et al.
        Cognitive-behavioral management of chemotherapy-related cognitive change.
        Psycho-Oncol: J Psychol, Soc Behav Dimens Cancer. 2007; 16: 772-777
        • Ferguson R.J.
        • et al.
        Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.
        Psycho-Oncol. 2012; 21: 176-186
        • Rebok G.W.
        • et al.
        Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults.
        J Am Geriatr Soc. 2014; 62: 16-24
        • Kesler S.
        • et al.
        Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors.
        Clin Breast Cancer. 2013; 13: 299-306
        • Von Ah D.
        • et al.
        Advanced cognitive training for breast cancer survivors: a randomized controlled trial.
        Breast Cancer Res Treat. 2012; 135
        • Poppelreuter M.
        • Weis J.
        • Bartsch H.
        Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy.
        J Psychosoc Oncol. 2009; 27: 274-296
        • McDougall G.J.
        • et al.
        Symptom management of affective and cognitive disturbance with a group of cancer survivors.
        Arch Psychiatr Nurs. 2011; 25: 24-35
        • Hurria A.
        Embracing the complexity of comorbidity.
        J Clin Oncol. 2011; 29: 4217-4218
        • Naik A.D.
        • et al.
        Health values and treatment goals of older, multimorbid adults facing life-threatening illness.
        J Am Geriatr Soc. 2016; 64: 625-631
        • Von Ah D.
        • et al.
        Coping strategies and interventions for cognitive changes in patients with cancer.
        Semin Oncol Nurs. 2013; 29: 288-299
        • Benzing V.
        • et al.
        The Brainfit study: efficacy of cognitive training and exergaming in pediatric cancer survivors – a randomized controlled trial.
        BMC Cancer. 2018; 18: 18
        • Alfano C.M.
        • Pergolotti M.
        Next-generation cancer rehabilitation: a Giant step forward for patient care.
        Rehabil Nurs. 2018; 43: 186-194